Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.80
+0.07 (0.72%)
Dec 20, 2024, 4:00 PM EST - Market closed
Amicus Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$16.71
Upside
+70.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $17 → $12 | Buy → Hold | Downgrades | $17 → $12 | +22.45% | Dec 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $17 | Buy | Maintains | $16 → $17 | +73.47% | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +53.06% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +114.29% | Nov 7, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +53.06% | Oct 17, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +83.67% | Oct 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $20 | Buy | Reiterates | $20 | +104.08% | Sep 20, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +83.67% | Sep 6, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +63.27% | Aug 16, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 9, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $13 | Hold → Strong Buy | Upgrades | $13 | +32.65% | May 14, 2024 |
| UBS | UBS | Strong Buy Maintains $20 → $19 | Strong Buy | Maintains | $20 → $19 | +93.88% | May 10, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +93.88% | May 10, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +32.65% | May 10, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.